Back to Top

Aims & Scope

Psychedelic Medicine is the only peer-reviewed, evidence-based resource solely focused on this rapidly expanding area of research. As psychedelic substances move into the mainstream with a growing number of clinical research programs, increasing industry investment, and accelerating legalization/decriminalization measures – Psychedelic Medicine is the central authority with timely coverage on every aspect of psychedelic medicine.

Psychedelic Medicine provides rapid, fair peer-review, and welcomes original research papers including basic science, clinical, and translational research, as well as medical applications.

Psychedelic Medicine coverage includes:

  • Serotonin and serotonin receptors, signaling, functional selectivity, and ligand bias
  • Tryptamines (e.g. LSD, psilocybin, psilocin, DMT, 5-MeO-DMT)
  • Lysergamides (e.g. LSD)
  • Addiction
  • Animal models 
  • Drug discovery 
  • Effects on mental disorders
  • fMRI
  • Entactogens
  • Neuroplasticity
  • Palliative care
  • Phenethylamines (e.g. mescaline, DOI)
  • Psychiatry 
  • Psychoactive substances (e.g. ibogaine)
  • Psychopharmacology 
  • Psychotherapy
  • And more

Psychedelic Medicine is under the editorial leadership of Co-Editors-in-Chief: Peter Hendricks, PhD Professor and Director of Research, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham and Charles Nichols, PhD, Professor of Pharmacology, Louisiana State University Health Sciences Center. View the entire editorial board.

Audience: Pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, as well as addiction specialists, and regulators and policymakers.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.